The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
July 1st 2025
The findings contradict previous research suggesting high-risk patients with multiple myeloma were more likely to have a higher percentage of regulatory T cells (Tregs).
High-Risk Patients Benefit Significantly From Early Follow-up Post Hospital Discharge
April 20th 2015While most patients do not benefit from early follow-up after they are discharged from the hospital, researchers from Duke University Medical Center and Community Care of North Carolina found follow-up within 7 days was associated with substantially lower readmission rates among patients with high clinical complexity and high risk of readmission.
Read More
Studies Find Keytruda Effective Against 3 Cancer Types
April 20th 2015One of the hot new cancer immunotherapy drugs, Merck & Co's Keytruda, strongly benefited patients with melanoma, lung cancer and mesothelioma, according to 3 studies presented at the American Association for Cancer Research conference.
Read More
AJMC, Joslin Diabetes Center Join Forces to Host Patient-Centered Diabetes Care in Boston
January 16th 2015The leading peer-reviewed journal in managed care and the world leader in diabetes research and clinical care will present the conference at the Renaissance Boston Waterfront April 16-17, 2015. Faculty presentations and panel discussions will cover clinical, behavioral and technological aspects of care for persons with type 1 and type 2 diabetes mellitus.
Read More
Effective Implementation of Collaborative Care for Depression: What Is Needed?
Factors most important for successful implementation of collaborative care for depression differ for patient activation versus achieving remission; both are critical to program success.
Read More
Potential Role of Network Meta-Analysis in Value-Based Insurance Design
This study illustrates that where clinical trials are lacking, network meta-analysis can provide valuable insights into the potential clinical and economic benefits of value-based insurance design.
Read More